Jefferies Financial Group Downgrades DENTSPLY SIRONA (NASDAQ:XRAY) to Hold

DENTSPLY SIRONA (NASDAQ:XRAY) was downgraded by investment analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a research note issued on Thursday, MarketBeat.com reports. They presently have a $20.00 price target on the medical instruments supplier’s stock, down from their previous price target of $30.00. Jefferies Financial Group’s price objective would indicate a potential upside of 2.41% from the company’s current price.

Several other research firms also recently commented on XRAY. Morgan Stanley reduced their price target on shares of DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a research note on Tuesday, December 17th. Needham & Company LLC reduced their target price on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a research report on Friday, October 25th. Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Finally, Barrington Research decreased their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Ten research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $26.67.

DENTSPLY SIRONA Stock Performance

DENTSPLY SIRONA stock opened at $19.53 on Thursday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. The firm has a market capitalization of $3.88 billion, a P/E ratio of -9.43, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. DENTSPLY SIRONA has a 1-year low of $17.21 and a 1-year high of $35.68. The company’s 50-day moving average is $19.03 and its 200 day moving average is $22.68.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The firm had revenue of $951.00 million during the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. DENTSPLY SIRONA’s quarterly revenue was up .4% compared to the same quarter last year. During the same period last year, the company earned $0.49 EPS. Research analysts forecast that DENTSPLY SIRONA will post 1.84 EPS for the current year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Institutional investors and hedge funds have recently bought and sold shares of the company. UMB Bank n.a. lifted its holdings in shares of DENTSPLY SIRONA by 430.3% during the 3rd quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 753 shares during the last quarter. Capital Performance Advisors LLP purchased a new stake in DENTSPLY SIRONA in the third quarter valued at about $27,000. MassMutual Private Wealth & Trust FSB boosted its holdings in DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after acquiring an additional 1,232 shares in the last quarter. Kennebec Savings Bank purchased a new stake in shares of DENTSPLY SIRONA during the third quarter worth about $35,000. Finally, Van ECK Associates Corp acquired a new position in shares of DENTSPLY SIRONA during the third quarter valued at about $42,000. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.